{
    "2021-02-01": [
        [
            {
                "time": "",
                "original_text": "华大基因20亿定增落地：用于扩产升级，华泰证券获配12亿",
                "features": {
                    "keywords": [
                        "华大基因",
                        "定增",
                        "扩产升级",
                        "华泰证券"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华大基因(300676.SZ)披露定增报告书：华泰证券获配约12亿元",
                "features": {
                    "keywords": [
                        "华大基因",
                        "定增",
                        "华泰证券"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "2021年医药行业如何投资？高瓴A股医药公司持仓曝光",
                "features": {
                    "keywords": [
                        "医药行业",
                        "高瓴资本",
                        "投资策略"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "今日有11家公司接待机构调研",
                "features": {
                    "keywords": [
                        "机构调研",
                        "公司动态"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "13亿市值A股公司涉案400亿，锂电大牛股获机构扎堆调研",
                "features": {
                    "keywords": [
                        "涉案",
                        "锂电",
                        "机构调研"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "新能源",
                        "锂电池"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}